Astrek Innovations
PrivateLast Round
Seed
Dec 9, 2021
Total Funding Raised
$204,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Astrek Innovations operates in Healthcare & Life Sciences and is based in Kerala. Its latest recorded funding round was a Seed round in December 2021.
Astrek Innovations is a healthtech company that develops wearable robotic exoskeletons for lower-limb rehabilitation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics, Health IoT, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Astrek Innovations Comparables
Compare Astrek Innovations with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bionic Yantra | 93% | |
| GenElek Technologies | 93% | |
| Autonomyo | 81% |
For institutional investors. Book with your work email.
Astrek Innovations Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 9, 2021 | ||||
| Grant | Dec 7, 2021 | ||||
| Accelerator | Jul 4, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Astrek Innovations Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Start-Up Chile | Accelerator |
| IAN Group | Seed |
| Huddle Ventures | Seed |
| Department of Science & Technology | Grant |
| Centre for Innovation and Entrepreneurship (CIE), IIIT Hyderabad | Seed |
| HealthStart | Seed |
| Ministry of Electronics and Information Technology | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 79% MoM.
- May 2, 2026
Grew 33% QoQ, from 12 to 16 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 1, 2026
Astrek Innovations Pvt. Ltd. develops a lower-limb robotic exoskeleton in India that uses motor-assisted movement and machine learning to support walking rehabilitation, including for patients recovering from spinal cord injuries.
For institutional investors. Book with your work email.
Astrek Innovations Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Astrek Innovations's valuation, stock price, and market status.
Is Astrek Innovations a public or private company?
Astrek Innovations is a private company.
What is the current stock price of Astrek Innovations?
Astrek Innovations is a private company, so its shares have no public market price. Caplight tracks Astrek Innovations's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Astrek Innovations worth (valuation)?
Valuation information for Astrek Innovations is not publicly available.
Can I buy Astrek Innovations stock?
Astrek Innovations shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Astrek Innovations's last funding round?
Astrek Innovations's most recent funding round was Seed on December 9, 2021.
Who are the main investors in Astrek Innovations?
Key investors in Astrek Innovations include Start-Up Chile.
Will Astrek Innovations IPO soon?
No public IPO plans have been announced for Astrek Innovations.
How can I track Astrek Innovations secondary market activity?
Caplight tracks bids, offers, and trades in Astrek Innovations's shares on secondary markets.